Table 2 Neurological disorders detected in the study group (II) population
Diagnosis | Gender | |||
|---|---|---|---|---|
Male | Female | Total | ||
Guillian-Barre syndrome (GBS) | Number | 11 | 5 | 16 |
% | 42.3% | 20.8% | 32.0% | |
Myelitis/myelopathy | Number | 4 | 7 | 11 |
% | 15.4% | 29.2% | 22.0% | |
Myeloencepahalitis | Number | 3 | 0 | 3 |
% | 11.5% | 0.0% | 6.0% | |
Encephalitis | Number | 1 | 1 | 2 |
% | 3.8% | 4.2% | 4.0% | |
Myasthenia gravis | Number | 6 | 5 | 11 |
% | 23.1% | 20.8% | 22.0% | |
Chronic inflammatory demyelinating polyneuropathy | Number | 0 | 3 | 3 |
% | 0.0% | 12.5% | 6.0% | |
Acute demyelinating encephalomyelitis | Number | 1 | 3 | 4 |
% | 3.8% | 12.5% | 8.0% | |
Total | Number | 26 | 24 | 50 |
% | 100.0% | 100.0% | 100.0% | |